Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
More than 100 years ago, scientists started unlocking the mysteries of genes and inherited traits. Today, gene therapy holds …
During Heart Month, CSL Behring’s Dr. Danielle Duffy shares what she’s learned as a researcher and practicing cardiologist.
Moms and dads turn to this nonprofit for its rich library of videos that help families managing a child’s serious or rare dis…
Tab Lassiter – an employee with global vaccines leader Seqirus – endured a six-year battle before receiving a transplant. Eve…
At work, she’s a production coordinator ensuring that influenza vaccines are properly manufactured. On the football field, we…
“Our collective hope shines a light on progress made and challenges ahead,” CSL Limited CEO Paul Perreault said in a video me…
Meet this year’s grant recipients in Uplifting Athletes’ 2022 Young Investigator Draft. All are researching rare diseases.
Doctors make a plea for the kidneys, liver, spine and more, saying health-related emoji are good for patient communication.
A rare disease story in 28 languages can be a conversation starter for children who have rare diseases and build understandin…
Americas
Asia Pacific
Middle East
Europe